10-chloro-5-(3,5-dimethylimidazol-4-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-13-fluoro-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,12-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine

C142H147ClFN27O8 — CID 159597877

IUPAC10-chloro-5-(3,5-dimethylimidazol-4-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-13-fluoro-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,12-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine
SMILESCOc1ccc2c3ncc(-c4c(C)ncn4C)cc3n([C@H](c3ccccc3)C3CCOCC3)c2n1.Cc1cnn(C)c1-c1cnc2c3ccnc(N4CCOCC4)c3n(C(c3ccccc3)C3CCOCC3)c2c1.Cc1cnn(C)c1-c1cnc2c3ccnc(NCCO)c3n(C(c3ccccc3)C3CCOCC3)c2c1.Cc1ncn(C)c1-c1cnc2c3c(F)nccc3n([C@H](c3ccccc3)C3CCOCC3)c2c1.Cc1ncn(C)c1-c1cnc2c3ccnc(Cl)c3n([C@H](c3ccccc3)C3CCOCC3)c2c1
InChIInChI=1S/C31H34N6O2.C29H32N6O2.C28H29N5O2.C27H26ClN5O.C27H26FN5O/c1-21-19-34-35(2)28(21)24-18-26-27(33-20-24)25-8-11-32-31(36-12-16-39-17-13-36)30(25)37(26)29(22-6-4-3-5-7-22)23-9-14-38-15-10-23;1-19-17-33-34(2)26(19)22-16-24-25(32-18-22)23-8-11-30-29(31-12-13-36)28(23)35(24)27(20-6-4-3-5-7-20)21-9-14-37-15-10-21;1-18-26(32(2)17-30-18)21-15-23-25(29-16-21)22-9-10-24(34-3)31-28(22)33(23)27(19-7-5-4-6-8-19)20-11-13-35-14-12-20;1-17-24(32(2)16-31-17)20-14-22-23(30-15-20)21-8-11-29-27(28)26(21)33(22)25(18-6-4-3-5-7-18)19-9-12-34-13-10-19;1-17-25(32(2)16-31-17)20-14-22-24(30-15-20)23-21(8-11-29-27(23)28)33(22)26(18-6-4-3-5-7-18)19-9-12-34-13-10-19/h3-8,11,18-20,23,29H,9-10,12-17H2,1-2H3;3-8,11,16-18,21,27,36H,9-10,12-15H2,1-2H3,(H,30,31);4-10,15-17,20,27H,11-14H2,1-3H3;3-8,11,14-16,19,25H,9-10,12-13H2,1-2H3;3-8,11,14-16,19,26H,9-10,12-13H2,1-2H3/t;;27-;25-;26-/m..111/s1
InChIKeyMLBYLWQBDKNERY-SZNGGOOLSA-N
MW2414.37 g/mol
LogP26.59
Rot. Bonds25

About 10-chloro-5-(3,5-dimethylimidazol-4-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-13-fluoro-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,12-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine

10-chloro-5-(3,5-dimethylimidazol-4-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-13-fluoro-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,12-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine (PubChem CID 159597877) has the molecular formula C142H147ClFN27O8 and a molecular weight of 2414.37 g/mol. Its IUPAC name is 10-chloro-5-(3,5-dimethylimidazol-4-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-13-fluoro-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,12-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine.

Molecular Properties

Compound Name10-chloro-5-(3,5-dimethylimidazol-4-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-13-fluoro-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,12-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine
PubChem CID159597877
Molecular FormulaC142H147ClFN27O8
Molecular Weight2414.37 g/mol
Exact Mass2412.16
IUPAC Name10-chloro-5-(3,5-dimethylimidazol-4-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-13-fluoro-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,12-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine
SMILESCOc1ccc2c3ncc(-c4c(C)ncn4C)cc3n([C@H](c3ccccc3)C3CCOCC3)c2n1.Cc1cnn(C)c1-c1cnc2c3ccnc(N4CCOCC4)c3n(C(c3ccccc3)C3CCOCC3)c2c1.Cc1cnn(C)c1-c1cnc2c3ccnc(NCCO)c3n(C(c3ccccc3)C3CCOCC3)c2c1.Cc1ncn(C)c1-c1cnc2c3c(F)nccc3n([C@H](c3ccccc3)C3CCOCC3)c2c1.Cc1ncn(C)c1-c1cnc2c3ccnc(Cl)c3n([C@H](c3ccccc3)C3CCOCC3)c2c1
InChIInChI=1S/C31H34N6O2.C29H32N6O2.C28H29N5O2.C27H26ClN5O.C27H26FN5O/c1-21-19-34-35(2)28(21)24-18-26-27(33-20-24)25-8-11-32-31(36-12-16-39-17-13-36)30(25)37(26)29(22-6-4-3-5-7-22)23-9-14-38-15-10-23;1-19-17-33-34(2)26(19)22-16-24-25(32-18-22)23-8-11-30-29(31-12-13-36)28(23)35(24)27(20-6-4-3-5-7-20)21-9-14-37-15-10-21;1-18-26(32(2)17-30-18)21-15-23-25(29-16-21)22-9-10-24(34-3)31-28(22)33(23)27(19-7-5-4-6-8-19)20-11-13-35-14-12-20;1-17-24(32(2)16-31-17)20-14-22-23(30-15-20)21-8-11-29-27(28)26(21)33(22)25(18-6-4-3-5-7-18)19-9-12-34-13-10-19;1-17-25(32(2)16-31-17)20-14-22-24(30-15-20)23-21(8-11-29-27(23)28)33(22)26(18-6-4-3-5-7-18)19-9-12-34-13-10-19/h3-8,11,18-20,23,29H,9-10,12-17H2,1-2H3;3-8,11,16-18,21,27,36H,9-10,12-15H2,1-2H3,(H,30,31);4-10,15-17,20,27H,11-14H2,1-3H3;3-8,11,14-16,19,25H,9-10,12-13H2,1-2H3;3-8,11,14-16,19,26H,9-10,12-13H2,1-2H3/t;;27-;25-;26-/m..111/s1
InChIKeyMLBYLWQBDKNERY-SZNGGOOLSA-N
XLogP26.59
TPSA342.76 Ų
H-Bond Donors2
H-Bond Acceptors35
Rotatable Bonds25
Heavy Atoms179
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002414.37
LogP ≤ 526.59
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1035

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}

Analyze 10-chloro-5-(3,5-dimethylimidazol-4-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-13-fluoro-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,12-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 10-chloro-5-(3,5-dimethylimidazol-4-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-13-fluoro-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,12-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine?
The IUPAC name of 10-chloro-5-(3,5-dimethylimidazol-4-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-13-fluoro-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,12-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine (CID 159597877) is 10-chloro-5-(3,5-dimethylimidazol-4-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-13-fluoro-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,12-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine.
What is the SMILES notation for 10-chloro-5-(3,5-dimethylimidazol-4-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-13-fluoro-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,12-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine?
The canonical SMILES for 10-chloro-5-(3,5-dimethylimidazol-4-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-13-fluoro-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,12-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine is COc1ccc2c3ncc(-c4c(C)ncn4C)cc3n([C@H](c3ccccc3)C3CCOCC3)c2n1.Cc1cnn(C)c1-c1cnc2c3ccnc(N4CCOCC4)c3n(C(c3ccccc3)C3CCOCC3)c2c1.Cc1cnn(C)c1-c1cnc2c3ccnc(NCCO)c3n(C(c3ccccc3)C3CCOCC3)c2c1.Cc1ncn(C)c1-c1cnc2c3c(F)nccc3n([C@H](c3ccccc3)C3CCOCC3)c2c1.Cc1ncn(C)c1-c1cnc2c3ccnc(Cl)c3n([C@H](c3ccccc3)C3CCOCC3)c2c1.
What is the InChIKey of 10-chloro-5-(3,5-dimethylimidazol-4-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-13-fluoro-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,12-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine?
The InChIKey is MLBYLWQBDKNERY-SZNGGOOLSA-N. The full InChI is InChI=1S/C31H34N6O2.C29H32N6O2.C28H29N5O2.C27H26ClN5O.C27H26FN5O/c1-21-19-34-35(2)28(21)24-18-26-27(33-20-24)25-8-11-32-31(36-12-16-39-17-13-36)30(25)37(26)29(22-6-4-3-5-7-22)23-9-14-38-15-10-23;1-19-17-33-34(2)26(19)22-16-24-25(32-18-22)23-8-11-30-29(31-12-13-36)28(23)35(24)27(20-6-4-3-5-7-20)21-9-14-37-15-10-21;1-18-26(32(2)17-30-18)21-15-23-25(29-16-21)22-9-10-24(34-3)31-28(22)33(23)27(19-7-5-4-6-8-19)20-11-13-35-14-12-20;1-17-24(32(2)16-31-17)20-14-22-23(30-15-20)21-8-11-29-27(28)26(21)33(22)25(18-6-4-3-5-7-18)19-9-12-34-13-10-19;1-17-25(32(2)16-31-17)20-14-22-24(30-15-20)23-21(8-11-29-27(23)28)33(22)26(18-6-4-3-5-7-18)19-9-12-34-13-10-19/h3-8,11,18-20,23,29H,9-10,12-17H2,1-2H3;3-8,11,16-18,21,27,36H,9-10,12-15H2,1-2H3,(H,30,31);4-10,15-17,20,27H,11-14H2,1-3H3;3-8,11,14-16,19,25H,9-10,12-13H2,1-2H3;3-8,11,14-16,19,26H,9-10,12-13H2,1-2H3/t;;27-;25-;26-/m..111/s1.
What are the key properties of 10-chloro-5-(3,5-dimethylimidazol-4-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-13-fluoro-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,12-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine?
10-chloro-5-(3,5-dimethylimidazol-4-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-13-fluoro-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,12-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine has a molecular weight of 2414.37 g/mol, XLogP of 26.59, 25 rotatable bonds, 2 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for 10-chloro-5-(3,5-dimethylimidazol-4-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-13-fluoro-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,12-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine is sourced from PubChem (CID 159597877), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).